|
ZCCHC14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.444300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.221400E-01 |
| Normal-vs-Stage2 |
7.462100E-02 |
| Normal-vs-Stage3 |
1.472580E-01 |
| Normal-vs-Stage4 |
1.978820E-01 |
| Stage1-vs-Stage2 |
3.708400E-01 |
| Stage1-vs-Stage3 |
8.822600E-01 |
| Stage1-vs-Stage4 |
9.516000E-01 |
| Stage2-vs-Stage3 |
4.770000E-01 |
| Stage2-vs-Stage4 |
4.665400E-01 |
| Stage3-vs-Stage4 |
9.596000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.752000E-02 |
| Normal-vs-AfricanAmerican |
5.526200E-01 |
| Normal-vs-Asian |
8.866400E-01 |
| Caucasian-vs-AfricanAmerican |
4.882000E-02 |
| Caucasian-vs-Asian |
1.643230E-01 |
| AfricanAmerican-vs-Asian |
4.658200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.075760E-01 |
| Normal-vs-Female |
1.191170E-01 |
| Male-vs-Female |
6.557200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.522600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.147800E-02 |
| Normal-vs-Age(61-80Yrs) |
2.750300E-02 |
| Normal-vs-Age(81-100Yrs) |
3.658600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.952100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.218200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.068600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.431000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.633800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.584600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.771200E-01 |
| Classical-VS-Follicular |
1.11799458579753E-11 |
| Classical-VS-Other |
3.629800E-01 |
| Classical-VS-Normal |
7.624200E-01 |
| Tall-VS-Follicular |
5.597600E-04 |
| Tall-VS-Other |
5.483600E-01 |
| Tall-VS-Normal |
3.306800E-01 |
| Follicular-VS-Other |
1.745820E-01 |
| Follicular-VS-Normal |
4.1599999999975E-05 |
| Other-VS-Normal |
3.803800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.844800E-03 |
| Normal-vs-N1 |
4.393000E-01 |
| N0-vs-N1 |
7.706300E-02 |
|
|
